T1	p 45 90	patients with isolated hypertriglyceridemia .
T2	p 356 401	patients with isolated hypertriglyceridemia .
T3	p 429 508	39 patients with elevated triglyceride levels and peripheral artery sclerosis ,
T4	p 1290 1324	with isolated hypertriglyceridemia
T5	p 1399 1411	triglyceride
T6	i 16 27	simvastatin
T7	i 294 315	simvastatin treatment
T8	i 541 581	simvastatin ( 40 mg daily ) or placebo .
T9	i 707 718	Simvastatin
T10	i 729 736	placebo
T11	i 1194 1200	statin
T12	o 68 88	hypertriglyceridemia
T13	o 117 136	triglyceride levels
T14	o 187 237	accelerated progression of coronary artery disease
T15	o 324 352	coagulation and fibrinolysis
T16	o 379 399	hypertriglyceridemia
T17	o 455 467	triglyceride
T18	o 582 650	Plasma lipids , glucose homeostasis markers and hemostasic variables
T19	o 778 816	plasma levels/activity of fibrinogen (
T20	o 864 876	factor VII (
T21	o 930 965	plasminogen activator inhibitor-1 (
T22	o 1041 1084	reduction in von Willebrand factor levels ,
T23	o 1111 1157	prothrombin and partial thromboplastin times .
T24	o 1239 1245	effect
T25	o 1249 1277	coagulation and fibrinolysis
T26	o 1304 1324	hypertriglyceridemia